These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29749541)

  • 1. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy.
    Li J; Pang J; Liu Y; Zhang J; Zhang C; Shen G; Song L
    Oncol Rep; 2018 Jul; 40(1):355-360. PubMed ID: 29749541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
    Zhang M; Wang J; Yao R; Wang L
    Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RRM2 promotes the progression of human glioblastoma.
    Li C; Zheng J; Chen S; Huang B; Li G; Feng Z; Wang J; Xu S
    J Cell Physiol; 2018 Oct; 233(10):6759-6767. PubMed ID: 29667764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
    Kang W; Tong JH; Chan AW; Zhao J; Wang S; Dong Y; Sin FM; Yeung S; Cheng AS; Yu J; To K
    Oncol Rep; 2014 Jun; 31(6):2579-86. PubMed ID: 24756820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells.
    Wu Z; Zhan Y; Wang L; Tong J; Zhang L; Lin M; Jin X; Jiang L; Lou Y; Qiu Y
    Biomed Pharmacother; 2020 Oct; 130():110556. PubMed ID: 32763815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting RRM2 to enhance the anticancer activity of chemotherapy.
    Zhan Y; Jiang L; Jin X; Ying S; Wu Z; Wang L; Yu W; Tong J; Zhang L; Lou Y; Qiu Y
    Biomed Pharmacother; 2021 Jan; 133():110996. PubMed ID: 33227712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SiRNA-Mediated
    Xue T; Wang L; Li Y; Song H; Chu H; Yang H; Guo A; Jiao J
    Int J Med Sci; 2019; 16(11):1510-1516. PubMed ID: 31673243
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer Fighting SiRNA-RRM2 Loaded Nanorobots.
    Sharma A; Kumar P; Ambasta RK
    Pharm Nanotechnol; 2020; 8(2):79-90. PubMed ID: 32003677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.
    Zuckerman JE; Hsueh T; Koya RC; Davis ME; Ribas A
    J Invest Dermatol; 2011 Feb; 131(2):453-60. PubMed ID: 20944646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β‑catenin signaling pathway.
    Liu X; Peng J; Zhou Y; Xie B; Wang J
    Mol Med Rep; 2019 Sep; 20(3):2159-2166. PubMed ID: 31322175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo.
    Heidel JD; Liu JY; Yen Y; Zhou B; Heale BS; Rossi JJ; Bartlett DW; Davis ME
    Clin Cancer Res; 2007 Apr; 13(7):2207-15. PubMed ID: 17404105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.
    Gao J; Chen H; Yu Y; Song J; Song H; Su X; Li W; Tong X; Qian W; Wang H; Dai J; Guo Y
    Biomaterials; 2013 Dec; 34(38):10084-98. PubMed ID: 24060417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
    Tang Q; Wu L; Xu M; Yan D; Shao J; Yan S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1368-1379. PubMed ID: 32763454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair.
    Lu AG; Feng H; Wang PX; Han DP; Chen XH; Zheng MH
    World J Gastroenterol; 2012 Sep; 18(34):4704-13. PubMed ID: 23002339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.
    Chow Z; Johnson J; Chauhan A; Jeong JC; Castle JT; Izumi T; Weiss H; Townsend CM; Schrader J; Anthony L; Yang ES; Evers BM; Rychahou P
    Cancer Lett; 2024 Aug; 596():216993. PubMed ID: 38801884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
    Das B; Jain N; Mallick B
    Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome‑protamine-DNA-siRNA complex with cell permeable peptides.
    Wang X; Wang X; Sun J; Fu S
    Int J Mol Med; 2018 Nov; 42(5):2393-2402. PubMed ID: 30106091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
    Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
    Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RRM2 is a potential prognostic biomarker with functional significance in glioma.
    Sun H; Yang B; Zhang H; Song J; Zhang Y; Xing J; Yang Z; Wei C; Xu T; Yu Z; Xu Z; Hou M; Ji M; Zhang Y
    Int J Biol Sci; 2019; 15(3):533-543. PubMed ID: 30745840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells.
    Yang PM; Lin LS; Liu TP
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.